These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 25711449)
21. Improving the Gastrointestinal Tolerability of Fumaric Acid Esters: Early Findings on Gastrointestinal Events with Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from the Phase 3, Open-Label EVOLVE-MS-1 Study. Palte MJ; Wehr A; Tawa M; Perkin K; Leigh-Pemberton R; Hanna J; Miller C; Penner N Adv Ther; 2019 Nov; 36(11):3154-3165. PubMed ID: 31538304 [TBL] [Abstract][Full Text] [Related]
22. An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis. Lorefice L; Fenu G; Cabras F; Frau J; Coghe GC; Loi L; Marrosu MG; Cocco E Mult Scler Relat Disord; 2016 May; 7():65-7. PubMed ID: 27237760 [TBL] [Abstract][Full Text] [Related]
24. Oral agents in multiple sclerosis. Lorefice L; Fenu G; Frau J; Coghe GC; Marrosu MG; Cocco E Antiinflamm Antiallergy Agents Med Chem; 2015; 14(1):15-25. PubMed ID: 25924620 [TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of cladribine tablets and dimethyl fumarate in the treatment of relapsing remitting multiple sclerosis in Spain. Ginestal R; Rubio-Terrés C; Morán OD; Rubio-Rodríguez D; Los Santos H; Ordoñez C; Sánchez-Magro I J Comp Eff Res; 2023 Feb; 12(2):e220193. PubMed ID: 36705064 [No Abstract] [Full Text] [Related]
26. Desensitization for immediate hypersensitivity to oral dimethyl fumarate (Tecfidera). Di Bona D; Albanesi M; Giliberti LA; Nico A; Rossi MP; Caiaffa MF; Macchia L J Allergy Clin Immunol Pract; 2017; 5(3):821-822. PubMed ID: 27888036 [No Abstract] [Full Text] [Related]
27. Venous thromboembolism in multiple sclerosis: a report of two cases with pulmonary embolism on dimethyl fumarate and available data from adverse event reporting systems. Time to include disease modifying drugs in the equation? Papathanasiou A; Abdel-Fahim R; Gilmore C; Evangelou N Clin Neurol Neurosurg; 2020 May; 192():105726. PubMed ID: 32062308 [No Abstract] [Full Text] [Related]
28. Acute pancreatitis: possible association of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis. Luo H; Bhatt H; Mohamad S; Uhrik E; Sen S; Mathew T; Yousif A J Neurol; 2015 Mar; 262(3):779-80. PubMed ID: 25626723 [No Abstract] [Full Text] [Related]
29. An update on new and emerging therapies for relapsing-remitting multiple sclerosis. Weinstock-Guttman B Am J Manag Care; 2013 Nov; 19(17 Suppl):s343-54. PubMed ID: 24494635 [TBL] [Abstract][Full Text] [Related]
30. [Update on Current Care Guideline: Multiple sclerosis]. Remes A; Airas L; Atula S; Färkkilä M; Hartikainen P; Koivisto K; Mäenpää E; Ruutiainen J; Sumelahti ML; Duodecim; 2015; 131(5):500-1. PubMed ID: 26237913 [TBL] [Abstract][Full Text] [Related]
35. The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis. Wicks P; Rasouliyan L; Katic B; Nafees B; Flood E; Sasané R BMC Res Notes; 2016 Sep; 9(1):434. PubMed ID: 27604188 [TBL] [Abstract][Full Text] [Related]
36. Cladribine (Mavenclad) for multiple sclerosis. Med Lett Drugs Ther; 2019 Jul; 61(1577):118-120. PubMed ID: 31381552 [No Abstract] [Full Text] [Related]
37. COVID-19 in multiple sclerosis patients treated with dimethyl fumarate. Capone F; Ferraro E; Motolese F; Di Lazzaro V J Neurol; 2021 Sep; 268(9):3132-3134. PubMed ID: 33611610 [No Abstract] [Full Text] [Related]
38. Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Pediatric Patients With Relapsing Multiple Sclerosis (FOCUS). Alroughani R; Das R; Penner N; Pultz J; Taylor C; Eraly S Pediatr Neurol; 2018 Jun; 83():19-24. PubMed ID: 29681490 [TBL] [Abstract][Full Text] [Related]
39. Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study. Kita M; Fox RJ; Phillips JT; Hutchinson M; Havrdova E; Sarda SP; Agarwal S; Kong J; Zhang A; Viglietta V; Sheikh SI; Seidman E; Dawson KT Mult Scler; 2014 Feb; 20(2):253-7. PubMed ID: 24150778 [TBL] [Abstract][Full Text] [Related]
40. Successful treatment with dimethyl fumarate in a child with relapsing-remitting multiple sclerosis. Saijo N; Abe Y; Oikawa Y; Okubo Y; Endo W; Numata-Uematsu Y; Takahashi T; Uematsu M Brain Dev; 2022 May; 44(5):353-356. PubMed ID: 35058083 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]